•  
  •  
  •  
  •  

2025-12-23 12:16:32

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  STELHoldings

Stock Report

  • STEL Holdings Ltd consolidated Q2 FY2026 profit up at Rs. 6.64 crores
  • STEL Holdings Ltd Q3FY25 net profit at Rs. 8.91 lakhs
  • STEL Holdings Ltd consolidated profit for Q1FY25 declines to Rs. 8.69 lakhs
  • STEL Holdings Ltd Q4 FY2023-24 consolidated net profit higher at Rs. 9.96 crores
  • STEL Holdings Ltd Q3FY24 net profit at Rs. 9.79 lakhs
  • STEL Holdings Ltd reports Rs. 2.98 crore consolidated PAT in Q2 FY24
  • STEL Holdings Ltd Q1FY24 consolidated PAT slumps QoQ to Rs. 22.53 lakhs
  • STEL Holdings Ltd Q4 FY2023 consolidated profit at Rs. 9.65 crores
  • STEL Holdings Ltd Q3 FY23 consolidated profit at Rs. 15.48 lakhs
  • STEL Holdings Ltd consolidated Q4FY22 PAT at Rs. 9.64 crores
  • STEL Holdings Q3FY22 consolidated net profit at Rs. 0.36 lakhs
  • Stel Holdings Ltd reports consolidated PAT of Rs. 4.31 crore in Q2FY22

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024